Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
Chronic infections with either hepatitis B or C virus (HBV or HCV) are among the most common risk factors for developing hepatocellular carcinoma (HCC). The hepatocarcinogenic potential of these viruses is mediated through a wide range of mechanisms, including the induction of chronic inflammation a...
Main Authors: | Saleh A. Alqahtani, Massimo Colombo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/11/3091 |
Similar Items
-
Concept of HBV and HCV as a risk factor and prevention of viral hepatitis-related hepatocellular carcinoma
by: Athraa Falah Alshimerry, et al.
Published: (2023-01-01) -
Exploring the prognostic significance of blood carnitine and acylcarnitines in hepatitis C virus-induced hepatocellular carcinoma
by: Ashraf Abbass Basuni, et al.
Published: (2024-03-01) -
De novo lipogenesis is elicited dramatically in human hepatocellular carcinoma especially in hepatitis C virus‐induced hepatocellular carcinoma
by: Shaojian Li, et al.
Published: (2020-09-01) -
The distribution of hepatitis C virus genotypes in patients with hepatocellular carcinoma
by: Ayfer Bakır, et al.
Published: (2019-10-01) -
Angiogenic output in viral hepatitis, C and B, and HCV-associated hepatocellular carcinoma
by: Mohamed A. Abdel Mohsen, et al.
Published: (2014-09-01)